These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 22105791)

  • 21. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interatrial shunt closure devices in patients with nickel allergy.
    Reddy BT; Patel JB; Powell DL; Michaels AD
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):647-51. PubMed ID: 19777603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter closure of perimembranous VSD: symmetric and asymmetric occluders.
    Lucas V
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):91. PubMed ID: 21181972
    [No Abstract]   [Full Text] [Related]  

  • 24. Transcatheter perimembranous ventricular septal defect closure with atrial septal occluder.
    Mahimarangaiah J; Srivastava A; Hemanasetty S
    J Invasive Cardiol; 2010 Jul; 22(7):E122-4. PubMed ID: 20603513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter closure of atrial septal defect with Amplatzer device in children aged less than 10 years old: immediate and late follow-up.
    Rossi RI; Cardoso Cde O; Machado PR; Francois LG; Horowitz ES; Sarmento-Leite R
    Catheter Cardiovasc Interv; 2008 Feb; 71(2):231-6. PubMed ID: 17985387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical analysis of transcatheter closure of perimembranous ventricular septal defects with occluders made in China.
    Li X; Li L; Wang X; Zhao HB; Zhang SY
    Chin Med J (Engl); 2011 Jul; 124(14):2117-22. PubMed ID: 21933612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow up of secundum atrial septal defect closure with the amplatzer septal occluder.
    Knepp MD; Rocchini AP; Lloyd TR; Aiyagari RM
    Congenit Heart Dis; 2010; 5(1):32-7. PubMed ID: 20136855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Device closure of atrial septal defect: medium-term outcome with special reference to complications.
    Sadiq M; Kazmi T; Rehman AU; Latif F; Hyder N; Qureshi SA
    Cardiol Young; 2012 Feb; 22(1):71-8. PubMed ID: 21740607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Factors influencing the choice of atrial septal occluder for transcatheter closure of secundum atrial septal defects].
    Zhang YS; Lan BD; Li H; He XM; Dai ZX; Wang HC; Zhang J; Li J; DU YJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Nov; 37(11):981-5. PubMed ID: 20137320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mid-term results of Solysafe® septal occluder for percutaneous closure of secundum atrial septal defects.
    Yılmazer MM; Yıldırım SV; Meşe T; Güven B; Demirpençe S; Özdemir R; Öner T; Tavlı V
    Turk Gogus Kalp Damar Cerrahisi Derg; 2018 Jan; 26(1):58-64. PubMed ID: 32082712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of transcatheter closure in adults with large or small atrial septal defects.
    Meyer MR; Kurz DJ; Bernheim AM; Kretschmar O; Eberli FR
    Springerplus; 2016; 5(1):1841. PubMed ID: 27818879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wire fractures in Solysafe septal occluders: a single center experience.
    Gielen S; Riede FT; Schuler G; Dähnert I
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1161-8. PubMed ID: 22105791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
    Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter closure of secundum atrial septal defect using the Amplatzer Septal Occluder: initial results of a single medical center in Taiwan.
    Lin MC; Fu YC; Jan SL; Lin WW; Chu KH; Ting CT; Chen YT; Chi CS
    Acta Paediatr Taiwan; 2005; 46(1):17-23. PubMed ID: 16302572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
    Johnson JN; Marquardt ML; Ackerman MJ; Asirvatham SJ; Reeder GS; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):254-61. PubMed ID: 21563292
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.